comparison of glp-1 agonists The Weight-loss Effect GLP-1RAs Glucagon-Like Peptide-1 Receptor in Non-diabetic Individuals with Overweight or Obesity: A Systematic Review with Meta-Analysis and Trial Sequential Analysis of Randomized Controlled Trials glp 1 agonist comparison Are

Safety issues of tirzepatide (pancreatitis and gallbladder or biliary disease) in type 2 diabetes and obesity: a systematic review and meta-analysis

Mounjaro, and other weight loss injections, like Ozempic and Wegovy, are similar

An observational cohort study involving 168 pregnant women exposed to GLP-1 receptor agonists during the first trimester found a 2.6% prevalence of major birth defects, comparable to 2.3% in the diabetic reference group

Shared decision-making should take place, considering their current health status

Douros, Maria B.N

Potent GLP-1 agonists exert effects by multiple mechanisms including delayed gastric emptying, increased glucose-dependent insulin secretion, reduced glucagon levels, and reduced food intake by CNS effects to cause appetite suppression